nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilotinib—CA6—Topiramate—migraine	0.0705	0.117	CbGbCtD
Nilotinib—CA7—Topiramate—migraine	0.0615	0.102	CbGbCtD
Nilotinib—CA9—Topiramate—migraine	0.0527	0.0878	CbGbCtD
Nilotinib—CA12—Topiramate—migraine	0.0527	0.0878	CbGbCtD
Nilotinib—CA1—Topiramate—migraine	0.0493	0.0821	CbGbCtD
Nilotinib—CA4—Topiramate—migraine	0.0464	0.0772	CbGbCtD
Nilotinib—CA2—Topiramate—migraine	0.0426	0.071	CbGbCtD
Nilotinib—ABCG2—Verapamil—migraine	0.0196	0.0326	CbGbCtD
Nilotinib—CYP2B6—Amitriptyline—migraine	0.0173	0.0289	CbGbCtD
Nilotinib—CYP2B6—Valproic Acid—migraine	0.0158	0.0263	CbGbCtD
Nilotinib—CYP2B6—Verapamil—migraine	0.0138	0.0229	CbGbCtD
Nilotinib—CYP2C8—Amitriptyline—migraine	0.0131	0.0219	CbGbCtD
Nilotinib—CYP2C8—Valproic Acid—migraine	0.012	0.0199	CbGbCtD
Nilotinib—ABCB1—Timolol—migraine	0.0115	0.0192	CbGbCtD
Nilotinib—CYP2D6—Timolol—migraine	0.0109	0.0181	CbGbCtD
Nilotinib—CYP2C8—Verapamil—migraine	0.0104	0.0173	CbGbCtD
Nilotinib—ABCB1—Propranolol—migraine	0.0103	0.0171	CbGbCtD
Nilotinib—CYP2D6—Propranolol—migraine	0.00968	0.0161	CbGbCtD
Nilotinib—CYP2C9—Amitriptyline—migraine	0.00916	0.0152	CbGbCtD
Nilotinib—ABCB1—Amitriptyline—migraine	0.00889	0.0148	CbGbCtD
Nilotinib—CYP2D6—Amitriptyline—migraine	0.00838	0.0139	CbGbCtD
Nilotinib—CYP2C9—Valproic Acid—migraine	0.00835	0.0139	CbGbCtD
Nilotinib—CYP2C9—Verapamil—migraine	0.00727	0.0121	CbGbCtD
Nilotinib—ABCB1—Verapamil—migraine	0.00705	0.0117	CbGbCtD
Nilotinib—CYP2D6—Verapamil—migraine	0.00665	0.0111	CbGbCtD
Nilotinib—CYP3A4—Propranolol—migraine	0.00616	0.0102	CbGbCtD
Nilotinib—CYP3A4—Amitriptyline—migraine	0.00533	0.00886	CbGbCtD
Nilotinib—CYP3A4—Valproic Acid—migraine	0.00485	0.00808	CbGbCtD
Nilotinib—CYP3A4—Topiramate—migraine	0.00438	0.00729	CbGbCtD
Nilotinib—CYP3A4—Verapamil—migraine	0.00423	0.00703	CbGbCtD
Nilotinib—EPHB3—nerve—migraine	0.00201	0.0206	CbGeAlD
Nilotinib—MAPK8—blood vessel—migraine	0.00192	0.0196	CbGeAlD
Nilotinib—EPHA4—nerve—migraine	0.00168	0.0172	CbGeAlD
Nilotinib—TIE1—blood vessel—migraine	0.00166	0.017	CbGeAlD
Nilotinib—MAPK8—neck—migraine	0.00137	0.014	CbGeAlD
Nilotinib—EPHB2—brainstem—migraine	0.00131	0.0134	CbGeAlD
Nilotinib—CDC42BPB—trigeminal ganglion—migraine	0.00131	0.0134	CbGeAlD
Nilotinib—MAPK14—blood vessel—migraine	0.00122	0.0124	CbGeAlD
Nilotinib—EPHB4—blood vessel—migraine	0.00115	0.0118	CbGeAlD
Nilotinib—EPHA2—blood vessel—migraine	0.00113	0.0116	CbGeAlD
Nilotinib—TEK—blood vessel—migraine	0.0011	0.0113	CbGeAlD
Nilotinib—MAPK8—brainstem—migraine	0.00105	0.0107	CbGeAlD
Nilotinib—EPHB3—trigeminal ganglion—migraine	0.000976	0.00998	CbGeAlD
Nilotinib—CDC42BPB—cardiovascular system—migraine	0.000945	0.00967	CbGeAlD
Nilotinib—CA1—nerve—migraine	0.000931	0.00952	CbGeAlD
Nilotinib—HCK—trigeminal ganglion—migraine	0.000897	0.00917	CbGeAlD
Nilotinib—MAPK14—neck—migraine	0.00087	0.0089	CbGeAlD
Nilotinib—EPHB3—brainstem—migraine	0.000864	0.00883	CbGeAlD
Nilotinib—MAPK8—cardiovascular system—migraine	0.000855	0.00874	CbGeAlD
Nilotinib—KIT—blood vessel—migraine	0.000799	0.00818	CbGeAlD
Nilotinib—PDGFRB—blood vessel—migraine	0.000781	0.00799	CbGeAlD
Nilotinib—LCK—trigeminal ganglion—migraine	0.000749	0.00766	CbGeAlD
Nilotinib—TIE1—cardiovascular system—migraine	0.000741	0.00758	CbGeAlD
Nilotinib—CA4—nerve—migraine	0.000728	0.00744	CbGeAlD
Nilotinib—EPHB2—head—migraine	0.000724	0.0074	CbGeAlD
Nilotinib—EPHA4—brainstem—migraine	0.000721	0.00738	CbGeAlD
Nilotinib—EPHB4—trigeminal ganglion—migraine	0.000712	0.00729	CbGeAlD
Nilotinib—EPHA2—trigeminal ganglion—migraine	0.000699	0.00715	CbGeAlD
Nilotinib—EPHA8—head—migraine	0.000694	0.0071	CbGeAlD
Nilotinib—EPHB2—nervous system—migraine	0.000686	0.00702	CbGeAlD
Nilotinib—TEK—trigeminal ganglion—migraine	0.000682	0.00697	CbGeAlD
Nilotinib—MAPK14—brainstem—migraine	0.000665	0.0068	CbGeAlD
Nilotinib—EPHB2—central nervous system—migraine	0.000661	0.00676	CbGeAlD
Nilotinib—EPHA8—nervous system—migraine	0.000658	0.00673	CbGeAlD
Nilotinib—EPHB6—trigeminal ganglion—migraine	0.000652	0.00667	CbGeAlD
Nilotinib—MAPK11—head—migraine	0.000645	0.0066	CbGeAlD
Nilotinib—CDC42BPB—head—migraine	0.00064	0.00655	CbGeAlD
Nilotinib—EPHA8—central nervous system—migraine	0.000634	0.00648	CbGeAlD
Nilotinib—EPHA8—cerebellum—migraine	0.000619	0.00633	CbGeAlD
Nilotinib—MAPK11—nervous system—migraine	0.000612	0.00626	CbGeAlD
Nilotinib—CDC42BPB—nervous system—migraine	0.000607	0.00621	CbGeAlD
Nilotinib—EPHA3—head—migraine	0.000607	0.00621	CbGeAlD
Nilotinib—MAPK11—central nervous system—migraine	0.000589	0.00602	CbGeAlD
Nilotinib—CDC42BPB—central nervous system—migraine	0.000584	0.00597	CbGeAlD
Nilotinib—CA3—cardiovascular system—migraine	0.000581	0.00595	CbGeAlD
Nilotinib—MAPK8—head—migraine	0.000579	0.00592	CbGeAlD
Nilotinib—EPHA6—head—migraine	0.000579	0.00592	CbGeAlD
Nilotinib—MAPK11—cerebellum—migraine	0.000576	0.00589	CbGeAlD
Nilotinib—EPHA3—nervous system—migraine	0.000575	0.00588	CbGeAlD
Nilotinib—KIT—neck—migraine	0.000572	0.00585	CbGeAlD
Nilotinib—CDC42BPB—cerebellum—migraine	0.000571	0.00584	CbGeAlD
Nilotinib—PDGFRB—neck—migraine	0.000559	0.00571	CbGeAlD
Nilotinib—MAP2K5—trigeminal ganglion—migraine	0.000557	0.0057	CbGeAlD
Nilotinib—EPHA3—central nervous system—migraine	0.000554	0.00566	CbGeAlD
Nilotinib—EPHA6—nervous system—migraine	0.000549	0.00561	CbGeAlD
Nilotinib—MAPK8—nervous system—migraine	0.000549	0.00561	CbGeAlD
Nilotinib—CSF1R—trigeminal ganglion—migraine	0.000544	0.00556	CbGeAlD
Nilotinib—MAPK14—cardiovascular system—migraine	0.000543	0.00555	CbGeAlD
Nilotinib—FGR—cardiovascular system—migraine	0.000541	0.00553	CbGeAlD
Nilotinib—LYN—head—migraine	0.000534	0.00546	CbGeAlD
Nilotinib—MAPK8—central nervous system—migraine	0.000528	0.0054	CbGeAlD
Nilotinib—EPHA6—central nervous system—migraine	0.000528	0.0054	CbGeAlD
Nilotinib—EPHB2—brain—migraine	0.000525	0.00537	CbGeAlD
Nilotinib—MAPK8—cerebellum—migraine	0.000516	0.00528	CbGeAlD
Nilotinib—EPHB4—cardiovascular system—migraine	0.000515	0.00526	CbGeAlD
Nilotinib—LYN—nervous system—migraine	0.000506	0.00518	CbGeAlD
Nilotinib—EPHA2—cardiovascular system—migraine	0.000505	0.00516	CbGeAlD
Nilotinib—EPHA8—brain—migraine	0.000503	0.00514	CbGeAlD
Nilotinib—TIE1—head—migraine	0.000502	0.00513	CbGeAlD
Nilotinib—KIT—trigeminal ganglion—migraine	0.000494	0.00505	CbGeAlD
Nilotinib—MAP2K5—brainstem—migraine	0.000493	0.00504	CbGeAlD
Nilotinib—TEK—cardiovascular system—migraine	0.000492	0.00504	CbGeAlD
Nilotinib—LYN—central nervous system—migraine	0.000488	0.00499	CbGeAlD
Nilotinib—PDGFRB—trigeminal ganglion—migraine	0.000482	0.00493	CbGeAlD
Nilotinib—EPHB3—head—migraine	0.000477	0.00488	CbGeAlD
Nilotinib—TIE1—nervous system—migraine	0.000476	0.00487	CbGeAlD
Nilotinib—MAPK11—brain—migraine	0.000468	0.00478	CbGeAlD
Nilotinib—CDC42BPB—brain—migraine	0.000464	0.00474	CbGeAlD
Nilotinib—TIE1—central nervous system—migraine	0.000458	0.00468	CbGeAlD
Nilotinib—EPHB3—nervous system—migraine	0.000453	0.00463	CbGeAlD
Nilotinib—TIE1—cerebellum—migraine	0.000448	0.00458	CbGeAlD
Nilotinib—PDGFRA—cardiovascular system—migraine	0.000446	0.00456	CbGeAlD
Nilotinib—EPHA3—brain—migraine	0.00044	0.0045	CbGeAlD
Nilotinib—HCK—head—migraine	0.000439	0.00449	CbGeAlD
Nilotinib—KIT—brainstem—migraine	0.000437	0.00447	CbGeAlD
Nilotinib—EPHB3—central nervous system—migraine	0.000436	0.00446	CbGeAlD
Nilotinib—ABL1—trigeminal ganglion—migraine	0.00043	0.0044	CbGeAlD
Nilotinib—BRAF—cerebellum—migraine	0.000429	0.00439	CbGeAlD
Nilotinib—EPHB3—cerebellum—migraine	0.000426	0.00436	CbGeAlD
Nilotinib—MAPK8—brain—migraine	0.000419	0.00429	CbGeAlD
Nilotinib—EPHA6—brain—migraine	0.000419	0.00429	CbGeAlD
Nilotinib—HCK—nervous system—migraine	0.000416	0.00425	CbGeAlD
Nilotinib—CA6—head—migraine	0.000416	0.00425	CbGeAlD
Nilotinib—CA4—neck—migraine	0.000409	0.00418	CbGeAlD
Nilotinib—MAP2K5—cardiovascular system—migraine	0.000402	0.00412	CbGeAlD
Nilotinib—HCK—central nervous system—migraine	0.0004	0.00409	CbGeAlD
Nilotinib—EPHA4—head—migraine	0.000399	0.00408	CbGeAlD
Nilotinib—CA3—head—migraine	0.000394	0.00403	CbGeAlD
Nilotinib—CSF1R—cardiovascular system—migraine	0.000393	0.00402	CbGeAlD
Nilotinib—ABL2—cerebellum—migraine	0.000389	0.00398	CbGeAlD
Nilotinib—LYN—brain—migraine	0.000387	0.00396	CbGeAlD
Nilotinib—CA7—cerebellum—migraine	0.000383	0.00392	CbGeAlD
Nilotinib—MAP4K1—brain—migraine	0.000381	0.0039	CbGeAlD
Nilotinib—ABL1—brainstem—migraine	0.00038	0.00389	CbGeAlD
Nilotinib—EPHA4—nervous system—migraine	0.000378	0.00387	CbGeAlD
Nilotinib—CA3—nervous system—migraine	0.000373	0.00382	CbGeAlD
Nilotinib—MAPK14—head—migraine	0.000368	0.00376	CbGeAlD
Nilotinib—FGR—head—migraine	0.000366	0.00374	CbGeAlD
Nilotinib—EPHA4—central nervous system—migraine	0.000364	0.00372	CbGeAlD
Nilotinib—TIE1—brain—migraine	0.000364	0.00372	CbGeAlD
Nilotinib—CA3—central nervous system—migraine	0.000359	0.00368	CbGeAlD
Nilotinib—KIT—cardiovascular system—migraine	0.000357	0.00365	CbGeAlD
Nilotinib—EPHA4—cerebellum—migraine	0.000356	0.00364	CbGeAlD
Nilotinib—BRAF—brain—migraine	0.000349	0.00357	CbGeAlD
Nilotinib—MAPK14—nervous system—migraine	0.000348	0.00356	CbGeAlD
Nilotinib—PDGFRB—cardiovascular system—migraine	0.000348	0.00356	CbGeAlD
Nilotinib—FGR—nervous system—migraine	0.000347	0.00355	CbGeAlD
Nilotinib—EPHB3—brain—migraine	0.000346	0.00354	CbGeAlD
Nilotinib—EPHA2—head—migraine	0.000342	0.0035	CbGeAlD
Nilotinib—CA2—neck—migraine	0.000339	0.00347	CbGeAlD
Nilotinib—CA9—cerebellum—migraine	0.000336	0.00344	CbGeAlD
Nilotinib—MAPK14—central nervous system—migraine	0.000335	0.00343	CbGeAlD
Nilotinib—FGR—central nervous system—migraine	0.000334	0.00342	CbGeAlD
Nilotinib—TEK—head—migraine	0.000333	0.00341	CbGeAlD
Nilotinib—MAPK14—cerebellum—migraine	0.000328	0.00335	CbGeAlD
Nilotinib—CA1—cardiovascular system—migraine	0.000326	0.00334	CbGeAlD
Nilotinib—EPHA2—nervous system—migraine	0.000324	0.00331	CbGeAlD
Nilotinib—CA14—cerebellum—migraine	0.000319	0.00326	CbGeAlD
Nilotinib—EPHB6—head—migraine	0.000319	0.00326	CbGeAlD
Nilotinib—HCK—brain—migraine	0.000318	0.00325	CbGeAlD
Nilotinib—TEK—nervous system—migraine	0.000316	0.00323	CbGeAlD
Nilotinib—ABL2—brain—migraine	0.000316	0.00323	CbGeAlD
Nilotinib—CA4—brainstem—migraine	0.000312	0.0032	CbGeAlD
Nilotinib—EPHA2—central nervous system—migraine	0.000312	0.00319	CbGeAlD
Nilotinib—CA7—brain—migraine	0.000311	0.00318	CbGeAlD
Nilotinib—EPHB4—cerebellum—migraine	0.000311	0.00318	CbGeAlD
Nilotinib—ABL1—cardiovascular system—migraine	0.00031	0.00318	CbGeAlD
Nilotinib—TEK—central nervous system—migraine	0.000304	0.00311	CbGeAlD
Nilotinib—EPHB6—nervous system—migraine	0.000302	0.00309	CbGeAlD
Nilotinib—PDGFRA—head—migraine	0.000302	0.00309	CbGeAlD
Nilotinib—TEK—cerebellum—migraine	0.000298	0.00304	CbGeAlD
Nilotinib—CA2—trigeminal ganglion—migraine	0.000293	0.00299	CbGeAlD
Nilotinib—EPHB6—central nervous system—migraine	0.000291	0.00298	CbGeAlD
Nilotinib—EPHA4—brain—migraine	0.000289	0.00295	CbGeAlD
Nilotinib—PDGFRA—nervous system—migraine	0.000286	0.00293	CbGeAlD
Nilotinib—CA3—brain—migraine	0.000285	0.00292	CbGeAlD
Nilotinib—EPHB6—cerebellum—migraine	0.000284	0.00291	CbGeAlD
Nilotinib—CA12—head—migraine	0.000279	0.00285	CbGeAlD
Nilotinib—PDGFRA—central nervous system—migraine	0.000276	0.00282	CbGeAlD
Nilotinib—MAP2K5—head—migraine	0.000273	0.00279	CbGeAlD
Nilotinib—ABCG2—trigeminal ganglion—migraine	0.000271	0.00277	CbGeAlD
Nilotinib—PDGFRA—cerebellum—migraine	0.00027	0.00276	CbGeAlD
Nilotinib—MAPK14—brain—migraine	0.000266	0.00272	CbGeAlD
Nilotinib—CSF1R—head—migraine	0.000266	0.00272	CbGeAlD
Nilotinib—FGR—brain—migraine	0.000265	0.00271	CbGeAlD
Nilotinib—CA12—nervous system—migraine	0.000264	0.0027	CbGeAlD
Nilotinib—CA14—brain—migraine	0.000259	0.00265	CbGeAlD
Nilotinib—CA2—brainstem—migraine	0.000259	0.00265	CbGeAlD
Nilotinib—MAP2K5—nervous system—migraine	0.000258	0.00264	CbGeAlD
Nilotinib—CA4—cardiovascular system—migraine	0.000255	0.00261	CbGeAlD
Nilotinib—CA12—central nervous system—migraine	0.000255	0.0026	CbGeAlD
Nilotinib—EPHB4—brain—migraine	0.000253	0.00258	CbGeAlD
Nilotinib—CSF1R—nervous system—migraine	0.000252	0.00258	CbGeAlD
Nilotinib—MAP2K5—central nervous system—migraine	0.000249	0.00254	CbGeAlD
Nilotinib—EPHA2—brain—migraine	0.000248	0.00253	CbGeAlD
Nilotinib—MAP2K5—cerebellum—migraine	0.000243	0.00249	CbGeAlD
Nilotinib—CSF1R—central nervous system—migraine	0.000243	0.00248	CbGeAlD
Nilotinib—TEK—brain—migraine	0.000242	0.00247	CbGeAlD
Nilotinib—KIT—head—migraine	0.000242	0.00247	CbGeAlD
Nilotinib—CSF1R—cerebellum—migraine	0.000237	0.00243	CbGeAlD
Nilotinib—PDGFRB—head—migraine	0.000236	0.00241	CbGeAlD
Nilotinib—EPHB6—brain—migraine	0.000231	0.00236	CbGeAlD
Nilotinib—KIT—nervous system—migraine	0.000229	0.00234	CbGeAlD
Nilotinib—PDGFRB—nervous system—migraine	0.000224	0.00229	CbGeAlD
Nilotinib—CA1—head—migraine	0.000221	0.00226	CbGeAlD
Nilotinib—KIT—central nervous system—migraine	0.00022	0.00225	CbGeAlD
Nilotinib—PDGFRA—brain—migraine	0.000219	0.00224	CbGeAlD
Nilotinib—ABCB1—blood vessel—migraine	0.000216	0.00221	CbGeAlD
Nilotinib—KIT—cerebellum—migraine	0.000215	0.0022	CbGeAlD
Nilotinib—PDGFRB—central nervous system—migraine	0.000215	0.0022	CbGeAlD
Nilotinib—CA2—cardiovascular system—migraine	0.000211	0.00216	CbGeAlD
Nilotinib—PDGFRB—cerebellum—migraine	0.00021	0.00215	CbGeAlD
Nilotinib—ABL1—head—migraine	0.00021	0.00215	CbGeAlD
Nilotinib—CA1—nervous system—migraine	0.000209	0.00214	CbGeAlD
Nilotinib—CA12—brain—migraine	0.000202	0.00207	CbGeAlD
Nilotinib—CA1—central nervous system—migraine	0.000202	0.00206	CbGeAlD
Nilotinib—ABL1—nervous system—migraine	0.000199	0.00204	CbGeAlD
Nilotinib—MAP2K5—brain—migraine	0.000197	0.00202	CbGeAlD
Nilotinib—CSF1R—brain—migraine	0.000193	0.00197	CbGeAlD
Nilotinib—ABL1—central nervous system—migraine	0.000192	0.00196	CbGeAlD
Nilotinib—ABL1—cerebellum—migraine	0.000188	0.00192	CbGeAlD
Nilotinib—CYP2B6—cardiovascular system—migraine	0.000181	0.00185	CbGeAlD
Nilotinib—CYP2C9—cardiovascular system—migraine	0.000179	0.00183	CbGeAlD
Nilotinib—KIT—brain—migraine	0.000175	0.00179	CbGeAlD
Nilotinib—CA4—head—migraine	0.000173	0.00177	CbGeAlD
Nilotinib—PDGFRB—brain—migraine	0.000171	0.00175	CbGeAlD
Nilotinib—CYP2D6—brainstem—migraine	0.000164	0.00168	CbGeAlD
Nilotinib—CA4—nervous system—migraine	0.000164	0.00167	CbGeAlD
Nilotinib—CA1—brain—migraine	0.00016	0.00164	CbGeAlD
Nilotinib—CA4—central nervous system—migraine	0.000158	0.00161	CbGeAlD
Nilotinib—CA4—cerebellum—migraine	0.000154	0.00158	CbGeAlD
Nilotinib—ABL1—brain—migraine	0.000152	0.00156	CbGeAlD
Nilotinib—CA2—head—migraine	0.000143	0.00146	CbGeAlD
Nilotinib—CA2—nervous system—migraine	0.000136	0.00139	CbGeAlD
Nilotinib—Haematuria—Topiramate—migraine	0.000134	0.000649	CcSEcCtD
Nilotinib—Anxiety—Valproic Acid—migraine	0.000134	0.000647	CcSEcCtD
Nilotinib—Hypersensitivity—Verapamil—migraine	0.000134	0.000647	CcSEcCtD
Nilotinib—ABCB1—trigeminal ganglion—migraine	0.000134	0.00137	CbGeAlD
Nilotinib—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.000133	0.000645	CcSEcCtD
Nilotinib—Epistaxis—Topiramate—migraine	0.000133	0.000642	CcSEcCtD
Nilotinib—Alopecia—Gabapentin—migraine	0.000133	0.000642	CcSEcCtD
Nilotinib—Discomfort—Valproic Acid—migraine	0.000133	0.000641	CcSEcCtD
Nilotinib—Vision blurred—Timolol—migraine	0.000132	0.00064	CcSEcCtD
Nilotinib—Mental disorder—Gabapentin—migraine	0.000132	0.000636	CcSEcCtD
Nilotinib—Dry mouth—Valproic Acid—migraine	0.000131	0.000635	CcSEcCtD
Nilotinib—Malnutrition—Gabapentin—migraine	0.000131	0.000632	CcSEcCtD
Nilotinib—Erythema—Gabapentin—migraine	0.000131	0.000632	CcSEcCtD
Nilotinib—CA2—central nervous system—migraine	0.000131	0.00134	CbGeAlD
Nilotinib—Dizziness—Propranolol—migraine	0.00013	0.000631	CcSEcCtD
Nilotinib—Asthenia—Verapamil—migraine	0.00013	0.00063	CcSEcCtD
Nilotinib—Confusional state—Valproic Acid—migraine	0.00013	0.000627	CcSEcCtD
Nilotinib—Flatulence—Gabapentin—migraine	0.000129	0.000623	CcSEcCtD
Nilotinib—Oedema—Valproic Acid—migraine	0.000129	0.000622	CcSEcCtD
Nilotinib—Bradycardia—Topiramate—migraine	0.000129	0.000622	CcSEcCtD
Nilotinib—Pruritus—Verapamil—migraine	0.000128	0.000621	CcSEcCtD
Nilotinib—Dysgeusia—Gabapentin—migraine	0.000128	0.000619	CcSEcCtD
Nilotinib—Infection—Valproic Acid—migraine	0.000128	0.000618	CcSEcCtD
Nilotinib—CA2—cerebellum—migraine	0.000128	0.00131	CbGeAlD
Nilotinib—Haemoglobin—Topiramate—migraine	0.000127	0.000614	CcSEcCtD
Nilotinib—Rhinitis—Topiramate—migraine	0.000127	0.000612	CcSEcCtD
Nilotinib—Back pain—Gabapentin—migraine	0.000126	0.000611	CcSEcCtD
Nilotinib—Haemorrhage—Topiramate—migraine	0.000126	0.000611	CcSEcCtD
Nilotinib—Hepatitis—Topiramate—migraine	0.000126	0.000611	CcSEcCtD
Nilotinib—Nervous system disorder—Valproic Acid—migraine	0.000126	0.00061	CcSEcCtD
Nilotinib—Vertigo—Timolol—migraine	0.000126	0.00061	CcSEcCtD
Nilotinib—Thrombocytopenia—Valproic Acid—migraine	0.000126	0.000609	CcSEcCtD
Nilotinib—Syncope—Timolol—migraine	0.000126	0.000609	CcSEcCtD
Nilotinib—Hypoaesthesia—Topiramate—migraine	0.000126	0.000608	CcSEcCtD
Nilotinib—Muscle spasms—Gabapentin—migraine	0.000126	0.000608	CcSEcCtD
Nilotinib—Tachycardia—Valproic Acid—migraine	0.000126	0.000607	CcSEcCtD
Nilotinib—Vomiting—Propranolol—migraine	0.000125	0.000607	CcSEcCtD
Nilotinib—Pharyngitis—Topiramate—migraine	0.000125	0.000606	CcSEcCtD
Nilotinib—CA4—brain—migraine	0.000125	0.00128	CbGeAlD
Nilotinib—Skin disorder—Valproic Acid—migraine	0.000125	0.000604	CcSEcCtD
Nilotinib—Urinary tract disorder—Topiramate—migraine	0.000125	0.000603	CcSEcCtD
Nilotinib—Oedema peripheral—Topiramate—migraine	0.000124	0.000602	CcSEcCtD
Nilotinib—Hyperhidrosis—Valproic Acid—migraine	0.000124	0.000602	CcSEcCtD
Nilotinib—Rash—Propranolol—migraine	0.000124	0.000602	CcSEcCtD
Nilotinib—Dermatitis—Propranolol—migraine	0.000124	0.000601	CcSEcCtD
Nilotinib—Diarrhoea—Verapamil—migraine	0.000124	0.0006	CcSEcCtD
Nilotinib—Connective tissue disorder—Topiramate—migraine	0.000124	0.0006	CcSEcCtD
Nilotinib—Palpitations—Timolol—migraine	0.000124	0.0006	CcSEcCtD
Nilotinib—Urethral disorder—Topiramate—migraine	0.000124	0.000599	CcSEcCtD
Nilotinib—Loss of consciousness—Timolol—migraine	0.000123	0.000597	CcSEcCtD
Nilotinib—Vision blurred—Gabapentin—migraine	0.000123	0.000596	CcSEcCtD
Nilotinib—Anorexia—Valproic Acid—migraine	0.000123	0.000593	CcSEcCtD
Nilotinib—Cough—Timolol—migraine	0.000122	0.000592	CcSEcCtD
Nilotinib—Tremor—Gabapentin—migraine	0.000122	0.000592	CcSEcCtD
Nilotinib—CYP2B6—head—migraine	0.000122	0.00125	CbGeAlD
Nilotinib—Visual impairment—Topiramate—migraine	0.000122	0.000589	CcSEcCtD
Nilotinib—Ill-defined disorder—Gabapentin—migraine	0.000121	0.000586	CcSEcCtD
Nilotinib—Hypertension—Timolol—migraine	0.000121	0.000586	CcSEcCtD
Nilotinib—Anaemia—Gabapentin—migraine	0.000121	0.000584	CcSEcCtD
Nilotinib—Hypotension—Valproic Acid—migraine	0.00012	0.000581	CcSEcCtD
Nilotinib—Dizziness—Verapamil—migraine	0.00012	0.00058	CcSEcCtD
Nilotinib—Chest pain—Timolol—migraine	0.000119	0.000578	CcSEcCtD
Nilotinib—Myalgia—Timolol—migraine	0.000119	0.000578	CcSEcCtD
Nilotinib—Arthralgia—Timolol—migraine	0.000119	0.000578	CcSEcCtD
Nilotinib—Erythema multiforme—Topiramate—migraine	0.000119	0.000578	CcSEcCtD
Nilotinib—Anxiety—Timolol—migraine	0.000119	0.000576	CcSEcCtD
Nilotinib—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.000119	0.000574	CcSEcCtD
Nilotinib—ABCG2—cerebellum—migraine	0.000118	0.00121	CbGeAlD
Nilotinib—Discomfort—Timolol—migraine	0.000118	0.000571	CcSEcCtD
Nilotinib—Eye disorder—Topiramate—migraine	0.000118	0.000571	CcSEcCtD
Nilotinib—Malaise—Gabapentin—migraine	0.000118	0.00057	CcSEcCtD
Nilotinib—Tinnitus—Topiramate—migraine	0.000118	0.00057	CcSEcCtD
Nilotinib—Vertigo—Gabapentin—migraine	0.000117	0.000568	CcSEcCtD
Nilotinib—Musculoskeletal discomfort—Valproic Acid—migraine	0.000117	0.000567	CcSEcCtD
Nilotinib—Flushing—Topiramate—migraine	0.000117	0.000567	CcSEcCtD
Nilotinib—Cardiac disorder—Topiramate—migraine	0.000117	0.000567	CcSEcCtD
Nilotinib—Syncope—Gabapentin—migraine	0.000117	0.000567	CcSEcCtD
Nilotinib—Nausea—Propranolol—migraine	0.000117	0.000567	CcSEcCtD
Nilotinib—Leukopenia—Gabapentin—migraine	0.000117	0.000566	CcSEcCtD
Nilotinib—Dry mouth—Timolol—migraine	0.000117	0.000565	CcSEcCtD
Nilotinib—Insomnia—Valproic Acid—migraine	0.000116	0.000563	CcSEcCtD
Nilotinib—CYP2B6—nervous system—migraine	0.000116	0.00119	CbGeAlD
Nilotinib—Paraesthesia—Valproic Acid—migraine	0.000116	0.000559	CcSEcCtD
Nilotinib—Palpitations—Gabapentin—migraine	0.000115	0.000559	CcSEcCtD
Nilotinib—Confusional state—Timolol—migraine	0.000115	0.000559	CcSEcCtD
Nilotinib—Vomiting—Verapamil—migraine	0.000115	0.000558	CcSEcCtD
Nilotinib—Loss of consciousness—Gabapentin—migraine	0.000115	0.000556	CcSEcCtD
Nilotinib—Dyspnoea—Valproic Acid—migraine	0.000115	0.000555	CcSEcCtD
Nilotinib—Angiopathy—Topiramate—migraine	0.000115	0.000554	CcSEcCtD
Nilotinib—Oedema—Timolol—migraine	0.000115	0.000554	CcSEcCtD
Nilotinib—Rash—Verapamil—migraine	0.000114	0.000553	CcSEcCtD
Nilotinib—Dermatitis—Verapamil—migraine	0.000114	0.000553	CcSEcCtD
Nilotinib—Immune system disorder—Topiramate—migraine	0.000114	0.000552	CcSEcCtD
Nilotinib—Cough—Gabapentin—migraine	0.000114	0.000552	CcSEcCtD
Nilotinib—Mediastinal disorder—Topiramate—migraine	0.000114	0.000551	CcSEcCtD
Nilotinib—Infection—Timolol—migraine	0.000114	0.00055	CcSEcCtD
Nilotinib—Headache—Verapamil—migraine	0.000114	0.00055	CcSEcCtD
Nilotinib—Chills—Topiramate—migraine	0.000113	0.000548	CcSEcCtD
Nilotinib—Dyspepsia—Valproic Acid—migraine	0.000113	0.000548	CcSEcCtD
Nilotinib—Hypertension—Gabapentin—migraine	0.000113	0.000546	CcSEcCtD
Nilotinib—Shock—Timolol—migraine	0.000113	0.000545	CcSEcCtD
Nilotinib—Nervous system disorder—Timolol—migraine	0.000112	0.000543	CcSEcCtD
Nilotinib—Decreased appetite—Valproic Acid—migraine	0.000112	0.000541	CcSEcCtD
Nilotinib—CYP2B6—central nervous system—migraine	0.000112	0.00114	CbGeAlD
Nilotinib—Alopecia—Topiramate—migraine	0.000112	0.00054	CcSEcCtD
Nilotinib—Arthralgia—Gabapentin—migraine	0.000111	0.000538	CcSEcCtD
Nilotinib—Myalgia—Gabapentin—migraine	0.000111	0.000538	CcSEcCtD
Nilotinib—Chest pain—Gabapentin—migraine	0.000111	0.000538	CcSEcCtD
Nilotinib—Skin disorder—Timolol—migraine	0.000111	0.000538	CcSEcCtD
Nilotinib—Gastrointestinal disorder—Valproic Acid—migraine	0.000111	0.000537	CcSEcCtD
Nilotinib—Fatigue—Valproic Acid—migraine	0.000111	0.000537	CcSEcCtD
Nilotinib—Anxiety—Gabapentin—migraine	0.000111	0.000536	CcSEcCtD
Nilotinib—Hyperhidrosis—Timolol—migraine	0.000111	0.000536	CcSEcCtD
Nilotinib—Mental disorder—Topiramate—migraine	0.000111	0.000535	CcSEcCtD
Nilotinib—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.00011	0.000534	CcSEcCtD
Nilotinib—Constipation—Valproic Acid—migraine	0.00011	0.000532	CcSEcCtD
Nilotinib—Pain—Valproic Acid—migraine	0.00011	0.000532	CcSEcCtD
Nilotinib—Malnutrition—Topiramate—migraine	0.00011	0.000532	CcSEcCtD
Nilotinib—Erythema—Topiramate—migraine	0.00011	0.000532	CcSEcCtD
Nilotinib—Discomfort—Gabapentin—migraine	0.00011	0.000532	CcSEcCtD
Nilotinib—Anorexia—Timolol—migraine	0.000109	0.000528	CcSEcCtD
Nilotinib—Dry mouth—Gabapentin—migraine	0.000109	0.000526	CcSEcCtD
Nilotinib—Flatulence—Topiramate—migraine	0.000108	0.000524	CcSEcCtD
Nilotinib—Nausea—Verapamil—migraine	0.000108	0.000521	CcSEcCtD
Nilotinib—Dysgeusia—Topiramate—migraine	0.000108	0.000521	CcSEcCtD
Nilotinib—Confusional state—Gabapentin—migraine	0.000108	0.00052	CcSEcCtD
Nilotinib—Hypotension—Timolol—migraine	0.000107	0.000518	CcSEcCtD
Nilotinib—Oedema—Gabapentin—migraine	0.000107	0.000516	CcSEcCtD
Nilotinib—Back pain—Topiramate—migraine	0.000106	0.000514	CcSEcCtD
Nilotinib—Feeling abnormal—Valproic Acid—migraine	0.000106	0.000513	CcSEcCtD
Nilotinib—Infection—Gabapentin—migraine	0.000106	0.000512	CcSEcCtD
Nilotinib—Muscle spasms—Topiramate—migraine	0.000106	0.000511	CcSEcCtD
Nilotinib—Gastrointestinal pain—Valproic Acid—migraine	0.000105	0.000509	CcSEcCtD
Nilotinib—Shock—Gabapentin—migraine	0.000105	0.000508	CcSEcCtD
Nilotinib—Nervous system disorder—Gabapentin—migraine	0.000105	0.000506	CcSEcCtD
Nilotinib—Thrombocytopenia—Gabapentin—migraine	0.000104	0.000505	CcSEcCtD
Nilotinib—Musculoskeletal discomfort—Timolol—migraine	0.000104	0.000505	CcSEcCtD
Nilotinib—Tachycardia—Gabapentin—migraine	0.000104	0.000503	CcSEcCtD
Nilotinib—CA2—brain—migraine	0.000104	0.00106	CbGeAlD
Nilotinib—Vision blurred—Topiramate—migraine	0.000104	0.000501	CcSEcCtD
Nilotinib—Skin disorder—Gabapentin—migraine	0.000104	0.000501	CcSEcCtD
Nilotinib—Insomnia—Timolol—migraine	0.000104	0.000501	CcSEcCtD
Nilotinib—Hyperhidrosis—Gabapentin—migraine	0.000103	0.000499	CcSEcCtD
Nilotinib—Tremor—Topiramate—migraine	0.000103	0.000498	CcSEcCtD
Nilotinib—Paraesthesia—Timolol—migraine	0.000103	0.000497	CcSEcCtD
Nilotinib—Urticaria—Valproic Acid—migraine	0.000102	0.000494	CcSEcCtD
Nilotinib—Dyspnoea—Timolol—migraine	0.000102	0.000494	CcSEcCtD
Nilotinib—Ill-defined disorder—Topiramate—migraine	0.000102	0.000493	CcSEcCtD
Nilotinib—Abdominal pain—Valproic Acid—migraine	0.000102	0.000492	CcSEcCtD
Nilotinib—Body temperature increased—Valproic Acid—migraine	0.000102	0.000492	CcSEcCtD
Nilotinib—Anorexia—Gabapentin—migraine	0.000102	0.000492	CcSEcCtD
Nilotinib—Anaemia—Topiramate—migraine	0.000102	0.000492	CcSEcCtD
Nilotinib—Dyspepsia—Timolol—migraine	0.000101	0.000488	CcSEcCtD
Nilotinib—Hypotension—Gabapentin—migraine	9.97e-05	0.000482	CcSEcCtD
Nilotinib—Decreased appetite—Timolol—migraine	9.96e-05	0.000482	CcSEcCtD
Nilotinib—Malaise—Topiramate—migraine	9.92e-05	0.00048	CcSEcCtD
Nilotinib—Gastrointestinal disorder—Timolol—migraine	9.89e-05	0.000478	CcSEcCtD
Nilotinib—CYP2C8—brain—migraine	9.88e-05	0.00101	CbGeAlD
Nilotinib—Vertigo—Topiramate—migraine	9.88e-05	0.000478	CcSEcCtD
Nilotinib—Fatigue—Timolol—migraine	9.87e-05	0.000478	CcSEcCtD
Nilotinib—Syncope—Topiramate—migraine	9.86e-05	0.000477	CcSEcCtD
Nilotinib—Leukopenia—Topiramate—migraine	9.84e-05	0.000476	CcSEcCtD
Nilotinib—Pain—Timolol—migraine	9.79e-05	0.000474	CcSEcCtD
Nilotinib—Musculoskeletal discomfort—Gabapentin—migraine	9.72e-05	0.00047	CcSEcCtD
Nilotinib—Palpitations—Topiramate—migraine	9.72e-05	0.00047	CcSEcCtD
Nilotinib—Loss of consciousness—Topiramate—migraine	9.66e-05	0.000467	CcSEcCtD
Nilotinib—ABCB1—cardiovascular system—migraine	9.65e-05	0.000988	CbGeAlD
Nilotinib—Insomnia—Gabapentin—migraine	9.65e-05	0.000467	CcSEcCtD
Nilotinib—ABCG2—brain—migraine	9.61e-05	0.000983	CbGeAlD
Nilotinib—Cough—Topiramate—migraine	9.59e-05	0.000464	CcSEcCtD
Nilotinib—Paraesthesia—Gabapentin—migraine	9.58e-05	0.000463	CcSEcCtD
Nilotinib—Dyspnoea—Gabapentin—migraine	9.51e-05	0.00046	CcSEcCtD
Nilotinib—Hypertension—Topiramate—migraine	9.49e-05	0.000459	CcSEcCtD
Nilotinib—Hypersensitivity—Valproic Acid—migraine	9.48e-05	0.000458	CcSEcCtD
Nilotinib—Feeling abnormal—Timolol—migraine	9.44e-05	0.000456	CcSEcCtD
Nilotinib—Dyspepsia—Gabapentin—migraine	9.39e-05	0.000454	CcSEcCtD
Nilotinib—Gastrointestinal pain—Timolol—migraine	9.37e-05	0.000453	CcSEcCtD
Nilotinib—Myalgia—Topiramate—migraine	9.36e-05	0.000453	CcSEcCtD
Nilotinib—Arthralgia—Topiramate—migraine	9.36e-05	0.000453	CcSEcCtD
Nilotinib—Chest pain—Topiramate—migraine	9.36e-05	0.000453	CcSEcCtD
Nilotinib—Anxiety—Topiramate—migraine	9.33e-05	0.000451	CcSEcCtD
Nilotinib—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	9.3e-05	0.00045	CcSEcCtD
Nilotinib—Decreased appetite—Gabapentin—migraine	9.27e-05	0.000448	CcSEcCtD
Nilotinib—Discomfort—Topiramate—migraine	9.25e-05	0.000447	CcSEcCtD
Nilotinib—Asthenia—Valproic Acid—migraine	9.23e-05	0.000446	CcSEcCtD
Nilotinib—Gastrointestinal disorder—Gabapentin—migraine	9.21e-05	0.000445	CcSEcCtD
Nilotinib—Fatigue—Gabapentin—migraine	9.2e-05	0.000445	CcSEcCtD
Nilotinib—Dry mouth—Topiramate—migraine	9.15e-05	0.000443	CcSEcCtD
Nilotinib—Constipation—Gabapentin—migraine	9.12e-05	0.000441	CcSEcCtD
Nilotinib—Pain—Gabapentin—migraine	9.12e-05	0.000441	CcSEcCtD
Nilotinib—Pruritus—Valproic Acid—migraine	9.1e-05	0.00044	CcSEcCtD
Nilotinib—Urticaria—Timolol—migraine	9.1e-05	0.00044	CcSEcCtD
Nilotinib—CYP2D6—head—migraine	9.09e-05	0.00093	CbGeAlD
Nilotinib—Body temperature increased—Timolol—migraine	9.05e-05	0.000438	CcSEcCtD
Nilotinib—Abdominal pain—Timolol—migraine	9.05e-05	0.000438	CcSEcCtD
Nilotinib—Confusional state—Topiramate—migraine	9.05e-05	0.000438	CcSEcCtD
Nilotinib—Oedema—Topiramate—migraine	8.97e-05	0.000434	CcSEcCtD
Nilotinib—Infection—Topiramate—migraine	8.91e-05	0.000431	CcSEcCtD
Nilotinib—CYP2B6—brain—migraine	8.86e-05	0.000907	CbGeAlD
Nilotinib—Shock—Topiramate—migraine	8.83e-05	0.000427	CcSEcCtD
Nilotinib—Diarrhoea—Valproic Acid—migraine	8.8e-05	0.000426	CcSEcCtD
Nilotinib—Nervous system disorder—Topiramate—migraine	8.8e-05	0.000426	CcSEcCtD
Nilotinib—Feeling abnormal—Gabapentin—migraine	8.79e-05	0.000425	CcSEcCtD
Nilotinib—Thrombocytopenia—Topiramate—migraine	8.79e-05	0.000425	CcSEcCtD
Nilotinib—Tachycardia—Topiramate—migraine	8.76e-05	0.000424	CcSEcCtD
Nilotinib—CYP3A4—nervous system—migraine	8.76e-05	0.000896	CbGeAlD
Nilotinib—Gastrointestinal pain—Gabapentin—migraine	8.72e-05	0.000422	CcSEcCtD
Nilotinib—Skin disorder—Topiramate—migraine	8.72e-05	0.000422	CcSEcCtD
Nilotinib—Hyperhidrosis—Topiramate—migraine	8.67e-05	0.00042	CcSEcCtD
Nilotinib—CYP2D6—nervous system—migraine	8.62e-05	0.000881	CbGeAlD
Nilotinib—Anorexia—Topiramate—migraine	8.55e-05	0.000414	CcSEcCtD
Nilotinib—Dizziness—Valproic Acid—migraine	8.51e-05	0.000412	CcSEcCtD
Nilotinib—Urticaria—Gabapentin—migraine	8.47e-05	0.00041	CcSEcCtD
Nilotinib—Hypersensitivity—Timolol—migraine	8.44e-05	0.000408	CcSEcCtD
Nilotinib—Body temperature increased—Gabapentin—migraine	8.43e-05	0.000408	CcSEcCtD
Nilotinib—Abdominal pain—Gabapentin—migraine	8.43e-05	0.000408	CcSEcCtD
Nilotinib—CYP3A4—central nervous system—migraine	8.43e-05	0.000862	CbGeAlD
Nilotinib—Hypotension—Topiramate—migraine	8.39e-05	0.000406	CcSEcCtD
Nilotinib—CYP2D6—central nervous system—migraine	8.3e-05	0.000849	CbGeAlD
Nilotinib—Asthenia—Timolol—migraine	8.22e-05	0.000397	CcSEcCtD
Nilotinib—Vomiting—Valproic Acid—migraine	8.18e-05	0.000396	CcSEcCtD
Nilotinib—Musculoskeletal discomfort—Topiramate—migraine	8.18e-05	0.000395	CcSEcCtD
Nilotinib—Insomnia—Topiramate—migraine	8.12e-05	0.000393	CcSEcCtD
Nilotinib—Rash—Valproic Acid—migraine	8.11e-05	0.000392	CcSEcCtD
Nilotinib—CYP2D6—cerebellum—migraine	8.11e-05	0.000829	CbGeAlD
Nilotinib—Dermatitis—Valproic Acid—migraine	8.1e-05	0.000392	CcSEcCtD
Nilotinib—Pruritus—Timolol—migraine	8.1e-05	0.000392	CcSEcCtD
Nilotinib—Headache—Valproic Acid—migraine	8.06e-05	0.00039	CcSEcCtD
Nilotinib—Paraesthesia—Topiramate—migraine	8.06e-05	0.00039	CcSEcCtD
Nilotinib—Dyspnoea—Topiramate—migraine	8e-05	0.000387	CcSEcCtD
Nilotinib—Dyspepsia—Topiramate—migraine	7.9e-05	0.000382	CcSEcCtD
Nilotinib—Hypersensitivity—Gabapentin—migraine	7.86e-05	0.00038	CcSEcCtD
Nilotinib—Diarrhoea—Timolol—migraine	7.84e-05	0.000379	CcSEcCtD
Nilotinib—Decreased appetite—Topiramate—migraine	7.8e-05	0.000377	CcSEcCtD
Nilotinib—Gastrointestinal disorder—Topiramate—migraine	7.75e-05	0.000375	CcSEcCtD
Nilotinib—Fatigue—Topiramate—migraine	7.74e-05	0.000374	CcSEcCtD
Nilotinib—Constipation—Topiramate—migraine	7.67e-05	0.000371	CcSEcCtD
Nilotinib—Pain—Topiramate—migraine	7.67e-05	0.000371	CcSEcCtD
Nilotinib—Asthenia—Gabapentin—migraine	7.65e-05	0.00037	CcSEcCtD
Nilotinib—Nausea—Valproic Acid—migraine	7.64e-05	0.00037	CcSEcCtD
Nilotinib—Dizziness—Timolol—migraine	7.57e-05	0.000366	CcSEcCtD
Nilotinib—Pruritus—Gabapentin—migraine	7.55e-05	0.000365	CcSEcCtD
Nilotinib—Feeling abnormal—Topiramate—migraine	7.39e-05	0.000358	CcSEcCtD
Nilotinib—Gastrointestinal pain—Topiramate—migraine	7.34e-05	0.000355	CcSEcCtD
Nilotinib—Diarrhoea—Gabapentin—migraine	7.3e-05	0.000353	CcSEcCtD
Nilotinib—Vomiting—Timolol—migraine	7.28e-05	0.000352	CcSEcCtD
Nilotinib—Rash—Timolol—migraine	7.22e-05	0.000349	CcSEcCtD
Nilotinib—Dermatitis—Timolol—migraine	7.22e-05	0.000349	CcSEcCtD
Nilotinib—Headache—Timolol—migraine	7.18e-05	0.000347	CcSEcCtD
Nilotinib—Urticaria—Topiramate—migraine	7.13e-05	0.000345	CcSEcCtD
Nilotinib—Abdominal pain—Topiramate—migraine	7.09e-05	0.000343	CcSEcCtD
Nilotinib—Body temperature increased—Topiramate—migraine	7.09e-05	0.000343	CcSEcCtD
Nilotinib—Dizziness—Gabapentin—migraine	7.05e-05	0.000341	CcSEcCtD
Nilotinib—Nausea—Timolol—migraine	6.8e-05	0.000329	CcSEcCtD
Nilotinib—Vomiting—Gabapentin—migraine	6.78e-05	0.000328	CcSEcCtD
Nilotinib—Rash—Gabapentin—migraine	6.73e-05	0.000325	CcSEcCtD
Nilotinib—Dermatitis—Gabapentin—migraine	6.72e-05	0.000325	CcSEcCtD
Nilotinib—Headache—Gabapentin—migraine	6.68e-05	0.000323	CcSEcCtD
Nilotinib—Hypersensitivity—Topiramate—migraine	6.61e-05	0.00032	CcSEcCtD
Nilotinib—CYP2D6—brain—migraine	6.59e-05	0.000674	CbGeAlD
Nilotinib—ABCB1—head—migraine	6.54e-05	0.000669	CbGeAlD
Nilotinib—Asthenia—Topiramate—migraine	6.44e-05	0.000311	CcSEcCtD
Nilotinib—Pruritus—Topiramate—migraine	6.35e-05	0.000307	CcSEcCtD
Nilotinib—Nausea—Gabapentin—migraine	6.34e-05	0.000306	CcSEcCtD
Nilotinib—ABCB1—nervous system—migraine	6.2e-05	0.000634	CbGeAlD
Nilotinib—Diarrhoea—Topiramate—migraine	6.14e-05	0.000297	CcSEcCtD
Nilotinib—ABCB1—central nervous system—migraine	5.97e-05	0.00061	CbGeAlD
Nilotinib—Dizziness—Topiramate—migraine	5.93e-05	0.000287	CcSEcCtD
Nilotinib—ABCB1—cerebellum—migraine	5.83e-05	0.000597	CbGeAlD
Nilotinib—Vomiting—Topiramate—migraine	5.71e-05	0.000276	CcSEcCtD
Nilotinib—Rash—Topiramate—migraine	5.66e-05	0.000274	CcSEcCtD
Nilotinib—Dermatitis—Topiramate—migraine	5.65e-05	0.000273	CcSEcCtD
Nilotinib—Headache—Topiramate—migraine	5.62e-05	0.000272	CcSEcCtD
Nilotinib—Nausea—Topiramate—migraine	5.33e-05	0.000258	CcSEcCtD
Nilotinib—ABCB1—brain—migraine	4.74e-05	0.000485	CbGeAlD
Nilotinib—KIT—Signaling Pathways—HTR1D—migraine	3.22e-05	0.00034	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—LRP1—migraine	3.21e-05	0.000339	CbGpPWpGaD
Nilotinib—CA14—Metabolism—MTHFR—migraine	3.2e-05	0.000339	CbGpPWpGaD
Nilotinib—MAPK11—Gene Expression—PGR—migraine	3.15e-05	0.000333	CbGpPWpGaD
Nilotinib—MAPK14—Regulation of toll-like receptor signaling pathway—TNF—migraine	3.14e-05	0.000332	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—CACNA1A—migraine	3.13e-05	0.000331	CbGpPWpGaD
Nilotinib—EPHB2—Developmental Biology—TNF—migraine	3.12e-05	0.00033	CbGpPWpGaD
Nilotinib—CA6—Metabolism—MTHFR—migraine	3.12e-05	0.00033	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—HTR1D—migraine	3.04e-05	0.000322	CbGpPWpGaD
Nilotinib—EPHB6—Developmental Biology—TNF—migraine	3.03e-05	0.000321	CbGpPWpGaD
Nilotinib—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—migraine	3.03e-05	0.00032	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—CALCRL—migraine	3.03e-05	0.00032	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—RAMP1—migraine	3.03e-05	0.00032	CbGpPWpGaD
Nilotinib—HCK—Disease—TGFBR2—migraine	3e-05	0.000317	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—HTR2B—migraine	2.99e-05	0.000316	CbGpPWpGaD
Nilotinib—MAPK11—Gene Expression—NOTCH3—migraine	2.93e-05	0.00031	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—LRP1—migraine	2.92e-05	0.000309	CbGpPWpGaD
Nilotinib—CA7—Metabolism—MTHFR—migraine	2.92e-05	0.000308	CbGpPWpGaD
Nilotinib—PDGFRA—Integrated Pancreatic Cancer Pathway—TNF—migraine	2.91e-05	0.000307	CbGpPWpGaD
Nilotinib—PDGFRB—MAPK Signaling Pathway—TNF—migraine	2.9e-05	0.000307	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—LRP1—migraine	2.89e-05	0.000306	CbGpPWpGaD
Nilotinib—EPHA6—Developmental Biology—TNF—migraine	2.85e-05	0.000301	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—HTR2B—migraine	2.83e-05	0.000299	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—NOTCH4—migraine	2.81e-05	0.000297	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—HTR1D—migraine	2.74e-05	0.00029	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—HTR1B—migraine	2.71e-05	0.000287	CbGpPWpGaD
Nilotinib—CA12—Metabolism—MTHFR—migraine	2.7e-05	0.000286	CbGpPWpGaD
Nilotinib—MAPK14—MAPK Signaling Pathway—TNF—migraine	2.69e-05	0.000285	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—HTR1D—migraine	2.68e-05	0.000284	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—NOTCH4—migraine	2.67e-05	0.000283	CbGpPWpGaD
Nilotinib—BRAF—Disease—CALCA—migraine	2.66e-05	0.000281	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—CACNA1A—migraine	2.66e-05	0.000281	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—LRP1—migraine	2.63e-05	0.000278	CbGpPWpGaD
Nilotinib—EPHA2—Developmental Biology—TNF—migraine	2.63e-05	0.000278	CbGpPWpGaD
Nilotinib—MAPK11—Innate Immune System—FOS—migraine	2.62e-05	0.000277	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—HTR1A—migraine	2.61e-05	0.000276	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—HTR1B—migraine	2.58e-05	0.000273	CbGpPWpGaD
Nilotinib—LCK—Disease—LRP1—migraine	2.57e-05	0.000272	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—PGR—migraine	2.57e-05	0.000272	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—TAC1—migraine	2.57e-05	0.000272	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—NPS—migraine	2.57e-05	0.000272	CbGpPWpGaD
Nilotinib—ABL1—Integrated Pancreatic Cancer Pathway—TNF—migraine	2.55e-05	0.00027	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—HTR2B—migraine	2.55e-05	0.00027	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—HTR1D—migraine	2.55e-05	0.000269	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—HTR2C—migraine	2.52e-05	0.000267	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—HTR2B—migraine	2.5e-05	0.000264	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—LRP1—migraine	2.49e-05	0.000263	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—HTR1A—migraine	2.48e-05	0.000262	CbGpPWpGaD
Nilotinib—MAPK14—Gene Expression—NOTCH4—migraine	2.46e-05	0.00026	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—EDNRA—migraine	2.45e-05	0.000259	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—NPS—migraine	2.44e-05	0.000258	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—TAC1—migraine	2.44e-05	0.000258	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—PGR—migraine	2.44e-05	0.000258	CbGpPWpGaD
Nilotinib—HCK—Disease—MTHFR—migraine	2.43e-05	0.000257	CbGpPWpGaD
Nilotinib—MAPK14—Integrated Pancreatic Cancer Pathway—TNF—migraine	2.43e-05	0.000257	CbGpPWpGaD
Nilotinib—KIT—Disease—CALCA—migraine	2.42e-05	0.000256	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—HTR2C—migraine	2.4e-05	0.000253	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—NOTCH3—migraine	2.39e-05	0.000253	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—HTR2B—migraine	2.37e-05	0.00025	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—CALCA—migraine	2.36e-05	0.00025	CbGpPWpGaD
Nilotinib—KIT—Innate Immune System—FOS—migraine	2.36e-05	0.00025	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—EDNRA—migraine	2.33e-05	0.000246	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—CALCA—migraine	2.29e-05	0.000242	CbGpPWpGaD
Nilotinib—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—migraine	2.27e-05	0.00024	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—NOTCH3—migraine	2.27e-05	0.00024	CbGpPWpGaD
Nilotinib—MAPK14—Gene Expression—PGR—migraine	2.25e-05	0.000238	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—CALCA—migraine	2.24e-05	0.000237	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—LRP1—migraine	2.24e-05	0.000237	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—NOTCH4—migraine	2.24e-05	0.000237	CbGpPWpGaD
Nilotinib—PDGFRA—Innate Immune System—FOS—migraine	2.23e-05	0.000236	CbGpPWpGaD
Nilotinib—ABCB1—Allograft Rejection—TNF—migraine	2.23e-05	0.000236	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—NOTCH4—migraine	2.22e-05	0.000235	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—HTR7—migraine	2.21e-05	0.000233	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—HTR1D—migraine	2.2e-05	0.000233	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—LRP1—migraine	2.2e-05	0.000232	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—HTR1B—migraine	2.16e-05	0.000228	CbGpPWpGaD
Nilotinib—CA4—Metabolism—MTHFR—migraine	2.15e-05	0.000228	CbGpPWpGaD
Nilotinib—BRAF—Disease—TGFBR2—migraine	2.14e-05	0.000227	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—HTR1B—migraine	2.14e-05	0.000226	CbGpPWpGaD
Nilotinib—HCK—Immune System—FOS—migraine	2.11e-05	0.000223	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—HTR7—migraine	2.1e-05	0.000222	CbGpPWpGaD
Nilotinib—MAPK14—Gene Expression—NOTCH3—migraine	2.09e-05	0.000221	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—LRP1—migraine	2.08e-05	0.00022	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—HTR1A—migraine	2.08e-05	0.00022	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—CALCA—migraine	2.07e-05	0.000218	CbGpPWpGaD
Nilotinib—CA2—Metabolism—MTHFR—migraine	2.07e-05	0.000218	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—HTR1A—migraine	2.06e-05	0.000218	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—PGR—migraine	2.05e-05	0.000217	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—NPS—migraine	2.05e-05	0.000217	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—TAC1—migraine	2.05e-05	0.000217	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—HTR2B—migraine	2.05e-05	0.000216	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—TAC1—migraine	2.03e-05	0.000215	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—NPS—migraine	2.03e-05	0.000215	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—PGR—migraine	2.03e-05	0.000215	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—NOTCH4—migraine	2.02e-05	0.000213	CbGpPWpGaD
Nilotinib—PDGFRB—Innate Immune System—FOS—migraine	2.01e-05	0.000213	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—HTR2C—migraine	2.01e-05	0.000212	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—HTR2C—migraine	1.99e-05	0.00021	CbGpPWpGaD
Nilotinib—CA1—Metabolism—MTHFR—migraine	1.98e-05	0.000209	CbGpPWpGaD
Nilotinib—LYN—Innate Immune System—FOS—migraine	1.97e-05	0.000208	CbGpPWpGaD
Nilotinib—ABL1—Innate Immune System—FOS—migraine	1.96e-05	0.000207	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—EDNRA—migraine	1.95e-05	0.000207	CbGpPWpGaD
Nilotinib—KIT—Disease—TGFBR2—migraine	1.95e-05	0.000206	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—CACNA1A—migraine	1.95e-05	0.000206	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—HTR1B—migraine	1.95e-05	0.000206	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—EDNRA—migraine	1.94e-05	0.000205	CbGpPWpGaD
Nilotinib—BLK—Immune System—FOS—migraine	1.91e-05	0.000202	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—FOS—migraine	1.91e-05	0.000202	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—NOTCH4—migraine	1.91e-05	0.000202	CbGpPWpGaD
Nilotinib—FGR—Immune System—FOS—migraine	1.91e-05	0.000202	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—NOTCH3—migraine	1.9e-05	0.000201	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—TGFBR2—migraine	1.9e-05	0.000201	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—NOTCH3—migraine	1.89e-05	0.000199	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—CALCA—migraine	1.88e-05	0.000199	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—HTR1A—migraine	1.88e-05	0.000198	CbGpPWpGaD
Nilotinib—MAPK14—Innate Immune System—FOS—migraine	1.87e-05	0.000197	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—CALCA—migraine	1.86e-05	0.000197	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—TAC1—migraine	1.85e-05	0.000195	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—PGR—migraine	1.85e-05	0.000195	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—NPS—migraine	1.85e-05	0.000195	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—TGFBR2—migraine	1.85e-05	0.000195	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—HTR1B—migraine	1.84e-05	0.000195	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—HTR2C—migraine	1.81e-05	0.000191	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—TGFBR2—migraine	1.81e-05	0.000191	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—LRP1—migraine	1.8e-05	0.00019	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—HTR1A—migraine	1.78e-05	0.000188	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—EDNRA—migraine	1.76e-05	0.000186	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—HTR7—migraine	1.76e-05	0.000186	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—TAC1—migraine	1.75e-05	0.000185	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—NPS—migraine	1.75e-05	0.000185	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—PGR—migraine	1.75e-05	0.000185	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—HTR7—migraine	1.74e-05	0.000184	CbGpPWpGaD
Nilotinib—BRAF—Disease—MTHFR—migraine	1.74e-05	0.000184	CbGpPWpGaD
Nilotinib—CA9—Metabolism—MTHFR—migraine	1.74e-05	0.000184	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—NOTCH4—migraine	1.72e-05	0.000182	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—NOTCH3—migraine	1.72e-05	0.000182	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—HTR2C—migraine	1.71e-05	0.000181	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—CALCA—migraine	1.7e-05	0.000179	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—NOTCH4—migraine	1.69e-05	0.000178	CbGpPWpGaD
Nilotinib—MAPK11—Gene Expression—ESR1—migraine	1.68e-05	0.000178	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—EDNRA—migraine	1.67e-05	0.000176	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—TGFBR2—migraine	1.66e-05	0.000176	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—HTR1B—migraine	1.66e-05	0.000176	CbGpPWpGaD
Nilotinib—LCK—Disease—CALCA—migraine	1.66e-05	0.000175	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—CACNA1A—migraine	1.65e-05	0.000174	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—HTR1B—migraine	1.63e-05	0.000172	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—NOTCH3—migraine	1.63e-05	0.000172	CbGpPWpGaD
Nilotinib—LCK—Innate Immune System—FOS—migraine	1.62e-05	0.000171	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—CALCA—migraine	1.61e-05	0.00017	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—HTR1A—migraine	1.6e-05	0.000169	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—NOTCH4—migraine	1.6e-05	0.000169	CbGpPWpGaD
Nilotinib—MAPK11—Developmental Biology—TNF—migraine	1.59e-05	0.000168	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—HTR7—migraine	1.59e-05	0.000168	CbGpPWpGaD
Nilotinib—KIT—Disease—MTHFR—migraine	1.58e-05	0.000167	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—NPS—migraine	1.58e-05	0.000167	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—PGR—migraine	1.58e-05	0.000167	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—TAC1—migraine	1.58e-05	0.000167	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—HTR1A—migraine	1.57e-05	0.000166	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—HTR2A—migraine	1.55e-05	0.000163	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—HTR2C—migraine	1.54e-05	0.000163	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—PGR—migraine	1.54e-05	0.000163	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—TAC1—migraine	1.54e-05	0.000163	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—NPS—migraine	1.54e-05	0.000163	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—HTR1B—migraine	1.54e-05	0.000163	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—FOS—migraine	1.52e-05	0.000161	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—TGFBR2—migraine	1.52e-05	0.00016	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—HTR2C—migraine	1.51e-05	0.00016	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—EDNRA—migraine	1.5e-05	0.000159	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—HTR7—migraine	1.5e-05	0.000159	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—TGFBR2—migraine	1.5e-05	0.000159	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—MTHFR—migraine	1.5e-05	0.000159	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—HTR1A—migraine	1.48e-05	0.000157	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—EDNRA—migraine	1.47e-05	0.000156	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—HTR2A—migraine	1.47e-05	0.000155	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—NOTCH3—migraine	1.46e-05	0.000155	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—TAC1—migraine	1.46e-05	0.000155	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—PGR—migraine	1.46e-05	0.000155	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—NPS—migraine	1.46e-05	0.000155	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—CALCA—migraine	1.45e-05	0.000153	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—CACNA1A—migraine	1.44e-05	0.000152	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—NOTCH3—migraine	1.43e-05	0.000152	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—HTR2C—migraine	1.43e-05	0.000152	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—CALCA—migraine	1.42e-05	0.00015	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—EDNRA—migraine	1.39e-05	0.000147	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—NOTCH4—migraine	1.38e-05	0.000146	CbGpPWpGaD
Nilotinib—KIT—Immune System—FOS—migraine	1.37e-05	0.000145	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—ESR1—migraine	1.37e-05	0.000145	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—TGFBR2—migraine	1.37e-05	0.000144	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—NOTCH3—migraine	1.36e-05	0.000144	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—CACNA1A—migraine	1.35e-05	0.000143	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—HTR7—migraine	1.35e-05	0.000143	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—MTHFR—migraine	1.35e-05	0.000143	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—CACNA1A—migraine	1.34e-05	0.000142	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—CALCA—migraine	1.34e-05	0.000142	CbGpPWpGaD
Nilotinib—LCK—Disease—TGFBR2—migraine	1.34e-05	0.000141	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—HTR1B—migraine	1.33e-05	0.000141	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—HTR7—migraine	1.32e-05	0.00014	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—ESR1—migraine	1.31e-05	0.000138	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—FOS—migraine	1.3e-05	0.000138	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—TGFBR2—migraine	1.29e-05	0.000137	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—HTR1A—migraine	1.28e-05	0.000136	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—NPS—migraine	1.26e-05	0.000134	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—TAC1—migraine	1.26e-05	0.000134	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—PGR—migraine	1.26e-05	0.000134	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—HTR7—migraine	1.26e-05	0.000133	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—HTR2C—migraine	1.24e-05	0.000131	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—HTR2A—migraine	1.23e-05	0.00013	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—HTR2A—migraine	1.22e-05	0.000129	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—EDNRA—migraine	1.21e-05	0.000127	CbGpPWpGaD
Nilotinib—MAPK14—Gene Expression—ESR1—migraine	1.2e-05	0.000127	CbGpPWpGaD
Nilotinib—LYN—Developmental Biology—TNF—migraine	1.2e-05	0.000127	CbGpPWpGaD
Nilotinib—ABL1—Developmental Biology—TNF—migraine	1.19e-05	0.000126	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—NOTCH3—migraine	1.18e-05	0.000124	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—FOS—migraine	1.17e-05	0.000124	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—TGFBR2—migraine	1.17e-05	0.000123	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—CALCA—migraine	1.16e-05	0.000123	CbGpPWpGaD
Nilotinib—LYN—Immune System—FOS—migraine	1.15e-05	0.000121	CbGpPWpGaD
Nilotinib—ABL1—Immune System—FOS—migraine	1.14e-05	0.000121	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—TGFBR2—migraine	1.14e-05	0.000121	CbGpPWpGaD
Nilotinib—MAPK14—Developmental Biology—TNF—migraine	1.14e-05	0.00012	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—HTR2A—migraine	1.11e-05	0.000117	CbGpPWpGaD
Nilotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—migraine	1.1e-05	0.000116	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—ESR1—migraine	1.09e-05	0.000116	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—FOS—migraine	1.09e-05	0.000115	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—HTR7—migraine	1.09e-05	0.000115	CbGpPWpGaD
Nilotinib—LCK—Disease—MTHFR—migraine	1.08e-05	0.000115	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—ESR1—migraine	1.08e-05	0.000115	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—TGFBR2—migraine	1.08e-05	0.000114	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—HTR2A—migraine	1.05e-05	0.000111	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—MTHFR—migraine	1.04e-05	0.00011	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—ESR1—migraine	9.86e-06	0.000104	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—HTR2A—migraine	9.48e-06	0.0001	CbGpPWpGaD
Nilotinib—LCK—Immune System—FOS—migraine	9.41e-06	9.95e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—TGFBR2—migraine	9.35e-06	9.88e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—ESR1—migraine	9.33e-06	9.87e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—HTR2A—migraine	9.28e-06	9.81e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CACNA1A—migraine	8.86e-06	9.36e-05	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—MTHFR—migraine	8.8e-06	9.3e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—HTR2A—migraine	8.79e-06	9.3e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—ESR1—migraine	8.41e-06	8.89e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—ESR1—migraine	8.23e-06	8.7e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—ESR1—migraine	7.81e-06	8.25e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—HTR2A—migraine	7.6e-06	8.04e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—ESR1—migraine	6.75e-06	7.13e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—MTHFR—migraine	6.45e-06	6.82e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—MTHFR—migraine	5.46e-06	5.77e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—MTHFR—migraine	4.76e-06	5.03e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—MTHFR—migraine	4.48e-06	4.74e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—MTHFR—migraine	4.44e-06	4.7e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—MTHFR—migraine	2.93e-06	3.1e-05	CbGpPWpGaD
